[{"NetIncomeLoss_1_Q2_USD":-25616000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":26792000.0,"ContractWithCustomerAssetNetCurrent_0_Q2_USD":3079000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":137000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1_Q2_USD":0.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_2_Q2_USD":0.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":34992000.0,"Depreciation_1_Q2_USD":1700000.0,"Depreciation_2_Q2_USD":3381000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":1563000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":388000.0,"AssetsCurrent_0_Q2_USD":322622000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-239000.0,"ContractWithCustomerLiability_0_Q2_USD":2074000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":10946296.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":2366000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":112000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":192000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_0_Q2_Security":0.0,"CommonStockSharesIssued_0_Q2_shares":68739866.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":309804000.0,"IncreaseDecreaseInAccountsReceivableRelatedParties_2_Q2_USD":-2127000.0,"Assets_0_Q2_USD":347284000.0,"ShareBasedCompensation_2_Q2_USD":7418000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":17965999.0,"CommitmentsAndContingencies_0_Q2_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":68305056.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":67850640.0,"GeneralAndAdministrativeExpense_1_Q2_USD":6794000.0,"ShortTermInvestments_0_Q2_USD":62778000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":76933000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":38494000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-91000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-471000.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q2_USD":5455000.0,"CommonStockValue_0_Q2_USD":69000.0,"ContractWithCustomerAssetNet_0_Q2_USD":0.0,"IncreaseDecreaseInPrepaidRent_2_Q2_USD":1378000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":7018000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":224000.0,"StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_0_Q2_shares":37467.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":65836000.0,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q2_USD":2534000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-44619000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-25424000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-6874000.0,"OtherAssetsNoncurrent_0_Q2_USD":5467000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":249317000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":541833000.0,"Liabilities_0_Q2_USD":46120000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":192000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"DeferredRentCreditCurrent_0_Q2_USD":2902000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":13389000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":312100000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":150000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"PaymentsToAcquireMachineryAndEquipment_2_Q2_USD":1445000.0,"CommonStockSharesOutstanding_0_Q2_shares":68739866.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"RestrictedCashNoncurrent_0_Q2_USD":1874000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":29399000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":4872000.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q2_USD":5294000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":33137000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":137000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3723000.0,"MarketableSecuritiesUnrealizedGainLoss_2_Q2_USD":100000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q2_USD":200000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":3719000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-38291000.0,"LiabilitiesCurrent_0_Q2_USD":33702000.0,"AccountsPayableCurrent_0_Q2_USD":1934000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":251191000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2_Q2_USD":1285000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":7448000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":5957000.0,"InterestBearingDepositsInBanks_0_Q2_USD":2300000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":1285000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":17321000.0,"NetIncomeLoss_2_Q2_USD":-44731000.0,"StockIssuedDuringPeriodValueEmployeeBenefitPlan_1_Q2_USD":119000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-2798000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-240875000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":190000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":10.05,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":3119000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"CommonStockSharesAuthorized_0_Q2_shares":400000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":44119000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":19755000.0,"OperatingIncomeLoss_2_Q2_USD":-46203000.0,"OperatingIncomeLoss_1_Q2_USD":-25533000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":24600000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":2074000.0,"PreferredStockValue_0_Q2_USD":null,"DeferredRentCreditNoncurrent_0_Q2_USD":7941000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":347284000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":50458000.0,"OperatingExpenses_2_Q2_USD":90322000.0,"OperatingExpenses_1_Q2_USD":45288000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":7634000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.66,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.38,"ProfitLoss_2_Q2_USD":-44731000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":4188000.0,"OperatingLeasesFutureMinimumPaymentsDueCurrent_0_Q2_USD":5141000.0,"DeferredOfferingCosts_0_Q2_USD":500000.0,"StockholdersEquity_0_Q2_USD":301164000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":309667000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q2_USD":18424000.0,"Ticker":"NGM","CIK":"1426332","name":"NGM BIOPHARMACEUTICALS INC","OfficialName":"NGM Biopharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1227500649.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200812"}]